[PRESS RELEASE] – STAMFORD, Conn., Sept. 8, 2025 – Curaleaf Holdings Inc., a leading international provider of consumer cannabis products, announced that it has been selected for inclusion into the S&P/TSX Composite Index under the health care sector, effective prior to the open of trading on Sept. 22, 2025.
This inclusion positions the company among the highest-capitalized and most actively traded stocks on the Toronto Stock Exchange (TSX). As the first U.S.-based cannabis operator to be included in the S&P/TSX Composite Index, the company is poised to gain increased visibility and credibility within one of North America's premier equity benchmarks.
"This marks a pivotal moment for Curaleaf and represents a significant moment for mainstream normalization across the broader cannabis industry," Curaleaf Chairman and CEO Boris Jordan said. "Being recognized among some of the most influential stocks in North America, and as the only U.S.-based cannabis operator currently in this index, validates our sector's growing legitimacy and long-term potential.
“Our inclusion reflects an expanded presence in public markets and broadens our access to institutional investment and index-linked vehicles as we navigate the industry's ongoing development, alongside potential regulatory catalysts. Our team's dedication has been the driving force behind this achievement, and I would like to extend my thanks to the Curaleaf team for their hard work and commitment."
